Designing and Operating Flexible, High-Containment Vaccine Manufacturing

November 15, 2017

Thomas Page, PhD, is vice-president, Engineering at FUJIFILM Diosynth Biotechnologies.

Pharmaceutical Technology, Pharmaceutical Technology-11-15-2017, Volume 2017 ebook, Issue 2

Pages: 26-30

A new facility type integrates next-generation mobile cleanroom systems.

Facilities for advanced therapies should be configurable to flexibly segregate production for late-stage and commercial multiproduct operation. Efficient design of a flexible and high-containment vaccine manufacturing facility that can meet all the challenges presented by the market requires a design philosophy that includes all the key control concepts: air, people, equipment, product, and liquid and solid waste. This article discusses best practices for such control and describes the use of modular, mobile cleanrooms.

Download the

Article Details

Pharmaceutical Technology and BioPharm International
eBook: Vaccine Development and Manufacturing 2017
November 2017
Pages: 26–30

Citation

When referring to this article, please cite it as T. Page, "Designing and Operating Flexible, High-Containment Vaccine Manufacturing," Pharmaceutical Technology and BioPharm International Vaccine Development and Manufacturing 2017 eBook (November 2017).